These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26767188)

  • 1. Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
    Gross CC; Schulte-Mecklenbeck A; Klinsing S; Posevitz-Fejfár A; Wiendl H; Klotz L
    Neurol Neuroimmunol Neuroinflamm; 2016 Feb; 3(1):e183. PubMed ID: 26767188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
    J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
    Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
    Front Immunol; 2018; 9():1097. PubMed ID: 29896193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
    Tahvili S; Zandieh B; Amirghofran Z
    Int J Dermatol; 2015 Jul; 54(7):e254-60. PubMed ID: 26108267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
    Spencer CM; Crabtree-Hartman EC; Lehmann-Horn K; Cree BA; Zamvil SS
    Neurol Neuroimmunol Neuroinflamm; 2015 Jun; 2(3):e76. PubMed ID: 25738172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
    Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
    Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
    Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
    Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.
    Medina S; Villarrubia N; Sainz de la Maza S; Lifante J; Costa-Frossard L; Roldán E; Picón C; Álvarez-Cermeño JC; Villar LM
    Mult Scler; 2018 Sep; 24(10):1317-1327. PubMed ID: 28653862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis.
    Ghadiri M; Rezk A; Li R; Evans A; Luessi F; Zipp F; Giacomini PS; Antel J; Bar-Or A
    Neurol Neuroimmunol Neuroinflamm; 2017 May; 4(3):e340. PubMed ID: 28377940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome.
    Stachowski J; Barth C; Michałkiewicz J; Krynicki T; Jarmoliński T; Runowski D; Lewandowska-Stachowiak M; Zaniew M; Warzywoda A; Bortkiewicz E; Dobosz M; Maciejewski J; Baldamus CA
    Pediatr Nephrol; 2000 Aug; 14(8-9):779-85. PubMed ID: 10955927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High CD4+:CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate.
    Balshi A; Saart E; Pandeya S; Dempsey J; Baber U; Sloane JA
    Mult Scler; 2023 Oct; 29(11-12):1465-1470. PubMed ID: 37572049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
    Zhang X; Tao Y; Chopra M; Ahn M; Marcus KL; Choudhary N; Zhu H; Markovic-Plese S
    J Immunol; 2013 Dec; 191(12):5867-74. PubMed ID: 24198283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.
    Mills EA; Ogrodnik MA; Plave A; Mao-Draayer Y
    Front Neurol; 2018; 9():5. PubMed ID: 29410647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.
    Heiligenhaus A; Li H; Schmitz A; Wasmuth S; Bauer D
    Clin Exp Immunol; 2005 Oct; 142(1):180-7. PubMed ID: 16178874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis.
    Holm Hansen R; Højsgaard Chow H; Christensen JR; Sellebjerg F; von Essen MR
    Mult Scler Relat Disord; 2020 Jan; 37():101451. PubMed ID: 31675639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
    Rep MH; van Oosten BW; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Clin Invest; 1997 May; 99(9):2225-31. PubMed ID: 9151795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.
    Montes Diaz G; Fraussen J; Van Wijmeersch B; Hupperts R; Somers V
    Sci Rep; 2018 May; 8(1):8194. PubMed ID: 29844361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.